Assistant Professor, Department of Hematology/Oncology
Appendix Cancer, Liver, Gall Bladder & Bile Duct Cancer, Esophageal Cancer, Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumors
Receiving a cancer diagnosis is a life-changing event. As a medical oncologist specializing in gastrointestinal cancers, it is my responsibility to help patients navigate the complexities and uncertainties of cancer and its therapies with compassion and respect. As every patient is unique and has unique needs, I believe in working together with each patient to develop an individualized plan of care. At Fox Chase Cancer Center, a team of experts in different specialties work together to provide a multidisciplinary and patient-centered approach, which are essential aspects of effective cancer care.
My research focus is improving the current landscape of cancer care by developing new knowledge and treatment strategies for patients with gastrointestinal cancers. At Fox Chase, my patients will have access to clinical trials, in addition to standard therapies for patients with gastrointestinal cancers.
Wookey V, Hall M. Detecting molecular residual disease to inform CRC treatment: are we ready for universal postoperative ctDNA screening? ASCO Daily News. June 16, 2022.
Gile J, Wookey V, Zemla T, Hassan H, Shi Q, Borad M, Bekaii-Saab T, Tran N, Mahipal A. Outcomes following FGFR inhibitor therapy in patients with cholangiocarcinoma: Multi-center single institution cohort experience. Poster Presentation. European Society for Medical Oncology World Congress on Gastrointestinal Cancer Annual Meeting. Barcelona, Spain, June 2022.
Soderberg L, Wookey V, Mitchell J, Jochum J, Tran N, Halfdanarson T, Hubbard J, Graham R, Mathis K, Mahipal A, Jin Z. Clinical outcomes of neoadjuvant treatment strategies in localized mismatch repair-deficient rectal cancer. Poster Presentation. American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, January 2022.
Wookey V, Mehler S, Stein M, Norton A, Grothey A, Somer B. “Impact of circulating tumor DNA (ctDNA) on clinical decisions in the adjuvant setting in patients with colorectal cancer (CRC)”. Poster Presentation. European Society for Medical Oncology World Congress on Gastrointestinal Cancer Annual Meeting [Virtual]. July 2021.
Wookey V, Schwartzberg L. Chapter 52: Hematologic support of the cancer patient; pp 766-784. In Principles and Practice of Palliative Care and Supportive Oncology, 5th edition: Wolters Kluwer; Philadelphia, PA; 2021. Ed: Berger AM, O’Neill JF.
Wookey V, Grothey A. Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer. Therap Adv Gastroenterol. June 2020; 14: 1-9.
Wookey V, Bufalino G, Vidal G, Somer B, Schwartzberg L, Grothey A. “Racial and Socioeconomic disparities in overall survival in colorectal cancer (CRC) at West Cancer Center (WCC), Memphis, TN”. Poster Presentation. American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, January 2020.
Patient comments